Nearly 30 drug makers will raise the prices of their medicines in January after a temporary halt to increases; more than 180,000 Virginians without insurance coverage will now have access to Medicaid coverage under the program’s expansion; despite lagging far behind 2017's enrollment numbers for most of open enrollment, the number of people who signed up for Affordable Care Act plans on HealthCare.gov was only down 4% after a surge of sign-ups last week.
Nearly 30 drug makers will raise the prices of their medicines in January after a temporary halt to increases. Reuters reported that some of the companies expected to increase prices were Allergan Plc, GlaxoSmithKline Plc, Amgen Inc, and Novartis AG. After criticisms from President Donald Trump, many drug makers had decided to pause drug price hikes. In California, where a new state law requires companies notify payers if they intend double-digit percentage increases over 2 years, 28 drug makers filed notifications for price increases.
More than 180,000 Virginians without insurance coverage will now have Medicaid coverage under the program’s expansion. The state General Assembly expanded Medicaid to cover people earning up to 138% of the federal poverty line, which made an additional 400,000 people eligible for Medicaid, according to the Richmond Times-Dispatch. Virginia’s Department of Medical Assistance Services expects 360,000 people to have enrolled by the end of 2019.
Throughout open enrollment, the number of people signing up for Affordable Care Act plans on HealthCare.gov had lagged behind 2017. However, after a surge of sign-ups in the last week, enrollment is now only down 4% compared with the same point last year, reported The New York Times. In the last week of enrollment, 4.3 million people signed up, which surpassed the 4.1 million who signed up in the last week of 2017. CMS Administrator Seema Verma suggested that the low unemployment rate may have contributed to the drop since more Americans likely have employer-based coverage. The number of sign-ups increased in 5 states: Florida, Hawaii, Mississippi, Oklahoma, and Wyoming.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More